ZNTL Stock Zentalis Pharmaceuticals (ZNTL, $8.84) was a top loser this quarter, falling -38.27%

A.I.dvisor
at Tickeron.com
06/15/24
Loading...
ZNTL - Zentalis Pharmaceuticals

Loading...

Price: $8.84
Daily change: -$0.68 (-7.14%)
Daily volume: 1.3M
3-month price change: -$5.48 (-38.27%)
Capitalization: $627.8M
Industry: Biotechnology
Zentalis Pharmaceuticals (ZNTL, $8.84) was a top loser over the last three months, falling -3 to $8.84 per share. A.I.dvisor analyzed 891 stocks in the Biotechnology Industry for the 3-month period ending June 14, 2024, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1359 Broadway
Phone
+1 212 433-3791
Employees
168
Web
https://www.zentalis.com